Your browser doesn't support javascript.
loading
Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium.
Erol, Cihan; Yekedüz, Emre; Tural, Deniz; Karakaya, Serdar; Sentürk Öztas, Nihan; Uçar, Gökhan; Kiliçkap, Saadettin; Ertürk, Ismail; Sever, Özlem Nuray; Arslan, Çagatay; Küçükarda, Ahmet; Can, Orçun; Balvan, Özlem; Yazgan, Sati Coskun; Özgüroglu, Mustafa; Öksüzoglu, Berna; Sendur, Mehmet Ali Nahit; Ürün, Yüksel.
Afiliação
  • Erol C; Department of Medical Oncology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.
  • Yekedüz E; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Tural D; Ankara University Cancer Research Institute, Ankara, Turkey.
  • Karakaya S; Department of Medical Oncology, Bakirköy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Sentürk Öztas N; Medical Oncology Department, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey.
  • Uçar G; Division of Medical Oncology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Kiliçkap S; Department of Medical Oncology, Ankara City Hospital, University of Health Sciences, Ankara, Turkey.
  • Ertürk I; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Sever ÖN; Department of Medical Oncology, Faculty of Medicine, Istinye University, Istanbul, Turkey.
  • Arslan Ç; Department of Medical Oncology, Gülhane Education and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Küçükarda A; Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
  • Can O; Department of Medical Oncology, Faculty of Medicine, Izmir University of Economics, Izmir, Turkey.
  • Balvan Ö; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
  • Yazgan SC; Department of Medical Oncology, Faculty of Medicine, Istinye University, Istanbul, Turkey.
  • Özgüroglu M; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey.
  • Öksüzoglu B; Department of Internal Medicine, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Sendur MAN; Division of Medical Oncology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Ürün Y; Medical Oncology Department, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey.
Urol Int ; 107(6): 595-601, 2023.
Article em En | MEDLINE | ID: mdl-36996793
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Urol Int Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Urol Int Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia